Indian pharma’s maverick thinker
Arun Kumar has led Strides Shasun into the Fortune India 500, off it, and into the next 500. He claims to not have a strategy, and that puzzles investors. He’s been buying and selling bits of the company, but finally seems to be in consolidation mode.
